Home > > > > > Report Detail

Global Pulmonary Arterial Hypertension (PAH) Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028

Publisher Name :
Date: 25-Apr-2023
No. of pages: 103

The Pulmonary Arterial Hypertension (PAH) Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.

This report elaborates the market size, market characteristics, and market growth of the Pulmonary Arterial Hypertension (PAH) Drugs industry, and breaks down according to the type, application, and consumption area of Pulmonary Arterial Hypertension (PAH) Drugs. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.

In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Pulmonary Arterial Hypertension (PAH) Drugs in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.

Key players in the global Pulmonary Arterial Hypertension (PAH) Drugs market covered in Chapter 11:

Merck KGaA

AstraZeneca PLC

Pfizer Inc.

Novartis International AG

Gilead Science Inc.

Daiichi Sankyo Company Limited

Actelion Pharmaceuticals Ltd (Johnson & Johnson)

United Therapeutics Corporation

Bayer Aktiengesellschaft

Arena Pharmaceuticals Inc.

GlaxoSmithKline PLC

In Chapter 3, on the basis of types, the Pulmonary Arterial Hypertension (PAH) Drugs market from 2018 to 2028 is primarily split into:

Prostacyclin and Prostacyclin Analogs

SGC Stimulators

ERA

PDE-5

Others

In Chapter 4, on the basis of applications, the Pulmonary Arterial Hypertension (PAH) Drugs market from 2018 to 2028 covers:

Hospitals

Clinics

Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2028) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:

North America (Covered in Chapter 6)

United States

Canada

Mexico

Europe (Covered in Chapter 7)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 8)

China

Japan

South Korea

Australia

India

Middle East and Africa (Covered in Chapter 9)

Saudi Arabia

UAE

Egypt

South Africa

South America (Covered in Chapter 10)

Brazil

Argentina

Columbia

Years considered for this report:

Historical Years: 2018-2022

Base Year: 2022

Estimated Year: 2023

Forecast Period: 2023-2028

Global Pulmonary Arterial Hypertension (PAH) Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028

Table of Content

1 Report Overview
1.1 Research Objectives
1.2 Study Scope
1.3 Key Market Segments
1.4 Market Investment Scenario Strategic

2 Industry Insights
2.1 Industry Ecosystem Analysis
2.1.1 Industry Chain Analysis
2.1.2 Distribution Channel Analysis
2.2 Market Trend Analysis
2.2.1 Growth Drivers
2.2.2 Industry Constraints and Challenges
2.3 Industry Trends Under COVID-19
2.3.1 Risk Assessment on COVID-19
2.3.2 Assessment of the Overall Impact of COVID-19 on the Industry
2.3.3 Pre COVID-19 and Post COVID-19 Market Scenario
2.4 Industry Innovation Prospect Analysis
2.5 The Impact of Covid-19 From the Perspective of Industry Chain

3 Global Pulmonary Arterial Hypertension (PAH) Drugs Market, By Product Type
3.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales, Revenue and Market Share by Types (2018-2023)
3.1.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales and Market Share by Types (2018-2023)
3.1.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Market Share by Types (2018-2023)
3.1.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Price by Types (2018-2023)
3.2 Key Trends by Types
3.3 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales, Price and Growth Rate of Prostacyclin and Prostacyclin Analogs (2018-2023)
3.4 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales, Price and Growth Rate of SGC Stimulators (2018-2023)
3.5 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales, Price and Growth Rate of ERA (2018-2023)
3.6 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales, Price and Growth Rate of PDE-5 (2018-2023)
3.7 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales, Price and Growth Rate of Others (2018-2023)

4 Global Pulmonary Arterial Hypertension (PAH) Drugs Market, By Applications
4.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption, Revenue and Market Share by Applications (2018-2023)
4.1.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption and Market Share by Applications (2018-2023)
4.1.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Market Share by Applications (2018-2023)
4.2 Hospitals
4.3 Clinics
4.4 Others

5 Global Pulmonary Arterial Hypertension (PAH) Drugs Market, By Regions
5.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Market Share by Regions
5.1.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales by Regions (2018-2023)
5.1.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Market Share by Regions (2018-2023)
5.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Market Share by Regions
5.2.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue by Regions (2018-2023)
5.2.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share by Regions (2018-2023)
5.3 Key Trends by Regions
5.3.1 Emerging Market Analysis

6 North America Pulmonary Arterial Hypertension (PAH) Drugs Market Analysis
6.1 North America Pulmonary Arterial Hypertension (PAH) Drugs Market Size
6.1.1 North America Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
6.1.2 North America Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
6.2 U.S. Pulmonary Arterial Hypertension (PAH) Drugs Market Size
6.3 Canada Pulmonary Arterial Hypertension (PAH) Drugs Market Size
6.4 Mexico Pulmonary Arterial Hypertension (PAH) Drugs Market Size
6.5 Key Macroeconomic Indicators
6.6 The Influence of COVID-19 on North America Market

7 Europe Pulmonary Arterial Hypertension (PAH) Drugs Market Analysis
7.1 Europe Pulmonary Arterial Hypertension (PAH) Drugs Market Size
7.1.1 Europe Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
7.1.2 Europe Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
7.2 Germany Pulmonary Arterial Hypertension (PAH) Drugs Market Size
7.3 United Kingdom Pulmonary Arterial Hypertension (PAH) Drugs Market Size
7.4 France Pulmonary Arterial Hypertension (PAH) Drugs Market Size
7.5 Italy Pulmonary Arterial Hypertension (PAH) Drugs Market Size
7.6 Spain Pulmonary Arterial Hypertension (PAH) Drugs Market Size
7.7 Russia Pulmonary Arterial Hypertension (PAH) Drugs Market Size
7.8 Key Macroeconomic Indicators
7.9 The Influence of COVID-19 on Europe Market

8 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Drugs Market Analysis
8.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Drugs Market Size
8.1.1 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
8.1.2 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
8.2 China Pulmonary Arterial Hypertension (PAH) Drugs Market Size
8.3 Japan Pulmonary Arterial Hypertension (PAH) Drugs Market Size
8.4 South Korea Pulmonary Arterial Hypertension (PAH) Drugs Market Size
8.5 Australia Pulmonary Arterial Hypertension (PAH) Drugs Market Size
8.6 India Pulmonary Arterial Hypertension (PAH) Drugs Market Size
8.7 Key Macroeconomic Indicators
8.8 The Influence of COVID-19 on Asia Pacific Market

9 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Drugs Market Analysis
9.1 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Drugs Market Size
9.1.1 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
9.1.2 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
9.2 Saudi Arabia Pulmonary Arterial Hypertension (PAH) Drugs Market Size
9.3 UAE Pulmonary Arterial Hypertension (PAH) Drugs Market Size
9.4 Egypt Pulmonary Arterial Hypertension (PAH) Drugs Market Size
9.5 South Africa Pulmonary Arterial Hypertension (PAH) Drugs Market Size
9.6 Key Macroeconomic Indicators
9.7 The Influence of COVID-19 on Middle East and Africa Market

10 South America Pulmonary Arterial Hypertension (PAH) Drugs Market Analysis
10.1 South America Pulmonary Arterial Hypertension (PAH) Drugs Market Size
10.1.1 South America Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
10.1.2 South America Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
10.2 Brazil Pulmonary Arterial Hypertension (PAH) Drugs Market Size
10.3 Argentina Pulmonary Arterial Hypertension (PAH) Drugs Market Size
10.4 Columbia Pulmonary Arterial Hypertension (PAH) Drugs Market Size
10.5 Key Macroeconomic Indicators
10.6 The Influence of COVID-19 on South America Market

11 Competition Landscape and Company Profiles
11.1 Merck KGaA
11.1.1 Merck KGaA Basic Information
11.1.2 Merck KGaA Product Profiles, Application and Specification
11.1.3 Merck KGaA Pulmonary Arterial Hypertension (PAH) Drugs Market Performance (2018-2023)
11.2 AstraZeneca PLC
11.2.1 AstraZeneca PLC Basic Information
11.2.2 AstraZeneca PLC Product Profiles, Application and Specification
11.2.3 AstraZeneca PLC Pulmonary Arterial Hypertension (PAH) Drugs Market Performance (2018-2023)
11.3 Pfizer Inc.
11.3.1 Pfizer Inc. Basic Information
11.3.2 Pfizer Inc. Product Profiles, Application and Specification
11.3.3 Pfizer Inc. Pulmonary Arterial Hypertension (PAH) Drugs Market Performance (2018-2023)
11.4 Novartis International AG
11.4.1 Novartis International AG Basic Information
11.4.2 Novartis International AG Product Profiles, Application and Specification
11.4.3 Novartis International AG Pulmonary Arterial Hypertension (PAH) Drugs Market Performance (2018-2023)
11.5 Gilead Science Inc.
11.5.1 Gilead Science Inc. Basic Information
11.5.2 Gilead Science Inc. Product Profiles, Application and Specification
11.5.3 Gilead Science Inc. Pulmonary Arterial Hypertension (PAH) Drugs Market Performance (2018-2023)
11.6 Daiichi Sankyo Company Limited
11.6.1 Daiichi Sankyo Company Limited Basic Information
11.6.2 Daiichi Sankyo Company Limited Product Profiles, Application and Specification
11.6.3 Daiichi Sankyo Company Limited Pulmonary Arterial Hypertension (PAH) Drugs Market Performance (2018-2023)
11.7 Actelion Pharmaceuticals Ltd (Johnson & Johnson)
11.7.1 Actelion Pharmaceuticals Ltd (Johnson & Johnson) Basic Information
11.7.2 Actelion Pharmaceuticals Ltd (Johnson & Johnson) Product Profiles, Application and Specification
11.7.3 Actelion Pharmaceuticals Ltd (Johnson & Johnson) Pulmonary Arterial Hypertension (PAH) Drugs Market Performance (2018-2023)
11.8 United Therapeutics Corporation
11.8.1 United Therapeutics Corporation Basic Information
11.8.2 United Therapeutics Corporation Product Profiles, Application and Specification
11.8.3 United Therapeutics Corporation Pulmonary Arterial Hypertension (PAH) Drugs Market Performance (2018-2023)
11.9 Bayer Aktiengesellschaft
11.9.1 Bayer Aktiengesellschaft Basic Information
11.9.2 Bayer Aktiengesellschaft Product Profiles, Application and Specification
11.9.3 Bayer Aktiengesellschaft Pulmonary Arterial Hypertension (PAH) Drugs Market Performance (2018-2023)
11.10 Arena Pharmaceuticals Inc.
11.10.1 Arena Pharmaceuticals Inc. Basic Information
11.10.2 Arena Pharmaceuticals Inc. Product Profiles, Application and Specification
11.10.3 Arena Pharmaceuticals Inc. Pulmonary Arterial Hypertension (PAH) Drugs Market Performance (2018-2023)
11.11 GlaxoSmithKline PLC
11.11.1 GlaxoSmithKline PLC Basic Information
11.11.2 GlaxoSmithKline PLC Product Profiles, Application and Specification
11.11.3 GlaxoSmithKline PLC Pulmonary Arterial Hypertension (PAH) Drugs Market Performance (2018-2023)

12 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast, By Type and Applications
12.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast by Types (2023-2028)
12.1.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Sales and Market Share by Types (2023-2028)
12.1.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Revenue and Market Share by Types (2023-2028)
12.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast by Applications (2023-2028)
12.2.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Consumption and Market Share by Applications (2023-2028)
12.2.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Revenue and Market Share by Applications (2023-2028)

13 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast, By Regions
13.1 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Sales and Market Share by Regions (2023-2028)
13.2 Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Revenue and Market Share by Regions (2023-2028)
13.3 North America Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast (2023-2028)
13.4 Europe Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast (2023-2028)
13.5 Asia-Pacific Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast (2023-2028)
13.6 Middle East and Africa Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast (2023-2028)
13.7 South America Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast (2023-2028)

14 Appendix
14.1 Methodology
14.2 Research Data Source
14.2.1 Secondary Data
14.2.2 Primary Data
14.2.3 Market Size Estimation
14.2.4 Legal Disclaimer

List of Tables and Figures

Table Pulmonary Arterial Hypertension (PAH) Drugs Key Market Segments
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Market Size and Growth Rate 2018-2028
Figure Channel Status of Pulmonary Arterial Hypertension (PAH) Drugs
Table Market Driving Factors of Pulmonary Arterial Hypertension (PAH) Drugs
Table Market Industry Constraints and Challenges of Pulmonary Arterial Hypertension (PAH) Drugs
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales by Types (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Share by Types (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue ($) by Types (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share by Types (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Price by Types (2018-2023)
Figure Global Prostacyclin and Prostacyclin Analogs Sales and Growth Rate (2018-2023)
Figure Global Prostacyclin and Prostacyclin Analogs Price (2018-2023)
Figure Global SGC Stimulators Sales and Growth Rate (2018-2023)
Figure Global SGC Stimulators Price (2018-2023)
Figure Global ERA Sales and Growth Rate (2018-2023)
Figure Global ERA Price (2018-2023)
Figure Global PDE-5 Sales and Growth Rate (2018-2023)
Figure Global PDE-5 Price (2018-2023)
Figure Global Others Sales and Growth Rate (2018-2023)
Figure Global Others Price (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption by Applications (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Consumption Share by Applications (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue ($) by Applications (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Share by Applications (2018-2023)
Figure Global Hospitals Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Clinics Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Others Consumption and Growth Rate (2018-2023) Sales and Growth Rate (2018-2023)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales and Growth Rate (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales by Regions (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Market Share by Regions (2018-2023)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Sales Market Share by Regions in 2022
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue and Growth Rate (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue by Regions (2018-2023)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share by Regions (2018-2023)
Figure Global Pulmonary Arterial Hypertension (PAH) Drugs Revenue Market Share by Regions in 2022
Figure North America Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Table North America Pulmonary Arterial Hypertension (PAH) Drugs Sales by Countries (2018-2023)
Figure North America Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue ($) and Growth Rate (2018-2023)
Table North America Pulmonary Arterial Hypertension (PAH) Drugs Revenue ($) by Countries (2018-2023)
Figure U.S. Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure U.S. Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Canada Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Canada Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Mexico Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Mexico Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure North America COVID-19 Status
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Table Europe Pulmonary Arterial Hypertension (PAH) Drugs Sales by Countries (2018-2023)
Figure Europe Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Table Europe Pulmonary Arterial Hypertension (PAH) Drugs Revenue by Countries (2018-2023)
Figure Germany Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Germany Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure United Kingdom Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure United Kingdom Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure France Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure France Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Italy Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Italy Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Spain Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Spain Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Russia Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Russia Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Europe COVID-19 Status
Figure Asia-Pacific Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Table Asia-Pacific Pulmonary Arterial Hypertension (PAH) Drugs Sales by Countries (2018-2023)
Figure Asia-Pacific Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Table Asia-Pacific Pulmonary Arterial Hypertension (PAH) Drugs Revenue by Countries (2018-2023)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure China Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Japan Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure South Korea Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure South Korea Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Australia Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Australia Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure India Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Table Middle East and Africa Pulmonary Arterial Hypertension (PAH) Drugs Sales by Countries (2018-2023)
Figure Middle East and Africa Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Table Middle East and Africa Pulmonary Arterial Hypertension (PAH) Drugs Revenue by Countries (2018-2023)
Figure Saudi Arabia Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Saudi Arabia Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure UAE Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure UAE Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Egypt Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Egypt Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure South Africa Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure South Africa Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure South America Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Table South America Pulmonary Arterial Hypertension (PAH) Drugs Sales by Countries (2018-2023)
Figure South America Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Table South America Pulmonary Arterial Hypertension (PAH) Drugs Revenue by Countries (2018-2023)
Figure Brazil Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Brazil Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Argentina Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Argentina Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Figure Columbia Pulmonary Arterial Hypertension (PAH) Drugs Market Sales and Growth Rate (2018-2023)
Figure Columbia Pulmonary Arterial Hypertension (PAH) Drugs Market Revenue and Growth Rate (2018-2023)
Table Merck KGaA Company Profile
Table Merck KGaA Production, Value, Price, Gross Margin 2018-2023
Figure Merck KGaA Production and Growth Rate
Figure Merck KGaA Value ($) Market Share 2018-2023
Table AstraZeneca PLC Company Profile
Table AstraZeneca PLC Production, Value, Price, Gross Margin 2018-2023
Figure AstraZeneca PLC Production and Growth Rate
Figure AstraZeneca PLC Value ($) Market Share 2018-2023
Table Pfizer Inc. Company Profile
Table Pfizer Inc. Production, Value, Price, Gross Margin 2018-2023
Figure Pfizer Inc. Production and Growth Rate
Figure Pfizer Inc. Value ($) Market Share 2018-2023
Table Novartis International AG Company Profile
Table Novartis International AG Production, Value, Price, Gross Margin 2018-2023
Figure Novartis International AG Production and Growth Rate
Figure Novartis International AG Value ($) Market Share 2018-2023
Table Gilead Science Inc. Company Profile
Table Gilead Science Inc. Production, Value, Price, Gross Margin 2018-2023
Figure Gilead Science Inc. Production and Growth Rate
Figure Gilead Science Inc. Value ($) Market Share 2018-2023
Table Daiichi Sankyo Company Limited Company Profile
Table Daiichi Sankyo Company Limited Production, Value, Price, Gross Margin 2018-2023
Figure Daiichi Sankyo Company Limited Production and Growth Rate
Figure Daiichi Sankyo Company Limited Value ($) Market Share 2018-2023
Table Actelion Pharmaceuticals Ltd (Johnson & Johnson) Company Profile
Table Actelion Pharmaceuticals Ltd (Johnson & Johnson) Production, Value, Price, Gross Margin 2018-2023
Figure Actelion Pharmaceuticals Ltd (Johnson & Johnson) Production and Growth Rate
Figure Actelion Pharmaceuticals Ltd (Johnson & Johnson) Value ($) Market Share 2018-2023
Table United Therapeutics Corporation Company Profile
Table United Therapeutics Corporation Production, Value, Price, Gross Margin 2018-2023
Figure United Therapeutics Corporation Production and Growth Rate
Figure United Therapeutics Corporation Value ($) Market Share 2018-2023
Table Bayer Aktiengesellschaft Company Profile
Table Bayer Aktiengesellschaft Production, Value, Price, Gross Margin 2018-2023
Figure Bayer Aktiengesellschaft Production and Growth Rate
Figure Bayer Aktiengesellschaft Value ($) Market Share 2018-2023
Table Arena Pharmaceuticals Inc. Company Profile
Table Arena Pharmaceuticals Inc. Production, Value, Price, Gross Margin 2018-2023
Figure Arena Pharmaceuticals Inc. Production and Growth Rate
Figure Arena Pharmaceuticals Inc. Value ($) Market Share 2018-2023
Table GlaxoSmithKline PLC Company Profile
Table GlaxoSmithKline PLC Production, Value, Price, Gross Margin 2018-2023
Figure GlaxoSmithKline PLC Production and Growth Rate
Figure GlaxoSmithKline PLC Value ($) Market Share 2018-2023
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Sales by Types (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Sales Share by Types (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Revenue ($) by Types (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Revenue Share by Types (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Consumption by Applications (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Consumption Share by Applications (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Revenue ($) by Applications (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Revenue Share by Applications (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Sales by Regions (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Sales Share by Regions (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Revenue ($) by Regions (2023-2028)
Table Global Pulmonary Arterial Hypertension (PAH) Drugs Market Forecast Revenue Share by Regions (2023-2028)
Figure North America Market Sales and Growth Rate Forecast (2023-2028)
Figure North America Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Europe Market Sales and Growth Rate Forecast (2023-2028)
Figure Europe Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Sales and Growth Rate Forecast (2023-2028)
Figure Asia-Pacific Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Sales and Growth Rate Forecast (2023-2028)
Figure Middle East and Africa Market Revenue ($) and Growth Rate Forecast (2023-2028)
Figure South America Market Sales and Growth Rate Forecast (2023-2028)
Figure South America Market Revenue ($) and Growth Rate Forecast (2023-2028)
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs